Streetbeat News

Products Services

PTN

Palatin Technologies has initiated a Phase 2 study of Bremelanotide, co-administered with a Phosphodiesterase 5 inhibitor, for erectile dysfunction in patients unresponsive to PDE5i monotherapy. Topline data is expected soon.

Portfolio Pulse from Benzinga Newsdesk

June 20, 2024 | 11:59 am

CMND

Clearmind Medicine has signed an exclusive patent licensing agreement with Yissum Research Development Company of the Hebrew University of Jerusalem. The agreement grants Clearmind exclusive rights to develop, manufacture, and commercialize compounds for treating PTSD and other mental health disorders.

Portfolio Pulse from Benzinga Newsdesk

June 20, 2024 | 11:58 am

TRVN

Trevena shares are trading higher after the company announced promising preclinical data for TRV045, showing long-term analgesic effects in a neuropathic pain model. Additionally, TRV045 results have led to further NIH-initiated studies in epilepsy prevention and treatment.

Portfolio Pulse from Benzinga Newsdesk

June 20, 2024 | 11:56 am

JAZZ

Jazz Pharmaceuticals' Suvecaltamide (JZP385) did not achieve statistical significance at 30mg versus placebo on the primary endpoint of change from baseline to week 12 on the Essential Tremor Rating Assessment Scale Modified Composite Outcome Score. The trial also did not meet the key secondary endpoint of the Clinical Global Impression-severity Scale.

Portfolio Pulse from Benzinga Newsdesk

June 20, 2024 | 11:56 am

TPST

Tempest Therapeutics shares are trading higher after the company announced that the TPST-1120 arm improved all efficacy endpoints compared to the standard of care (SoC) control in a study.

Portfolio Pulse from Benzinga Newsdesk

June 20, 2024 | 11:54 am

NVDA

Nvidia shares are trading higher due to ongoing momentum in the AI sector.

Portfolio Pulse from Benzinga Newsdesk

June 20, 2024 | 11:47 am

AAPL

Apple Inc. (NASDAQ:AAPL) has introduced new AI features, Apple Intelligence, exclusive to the iPhone 15 Pro and Pro Max models. Executives clarified that the limitation is due to hardware requirements, not a strategy to boost sales. The features require the A17 Pro chip and at least 8GB of RAM.

Portfolio Pulse from Rounak Jain

June 20, 2024 | 11:46 am

BTCUSD

Experts explain why summer months are typically slow for cryptocurrencies like Bitcoin and Ethereum, with lower trading volumes and market cap. However, fall and winter are expected to see increased activity and potential price gains, driven by returning investors and possible Federal Reserve rate cuts.

Portfolio Pulse from Aniket Verma

June 20, 2024 | 11:45 am

LLY

NVO

Eli Lilly & Co. (NYSE: LLY) has intensified its legal actions against counterfeit versions of its obesity drug, Zepbound, by filing lawsuits against various establishments for trademark violations, false advertising, and unfair competition. The company is addressing safety concerns related to counterfeit products and has made significant investments to meet the growing demand for its weight-loss and diabetes medications.

Portfolio Pulse from Benzinga Neuro

June 20, 2024 | 11:44 am

DELL

Dell shares are trading higher after Elon Musk announced that the company is assembling half of the racks for the supercomputer being built by xAI.

Portfolio Pulse from Benzinga Newsdesk

June 20, 2024 | 11:41 am